1. Home
  2. PLSE vs WD Comparison

PLSE vs WD Comparison

Compare PLSE & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$25.75

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$50.28

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
WD
Founded
2014
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
PLSE
WD
Price
$25.75
$50.28
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$22.00
$76.00
AVG Volume (30 Days)
344.4K
262.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
5.34%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
N/A
$1,234,306,000.00
Revenue This Year
$840.00
$20.60
Revenue Next Year
$287.54
$7.79
P/E Ratio
N/A
$109.62
Revenue Growth
N/A
8.99
52 Week Low
$12.56
$42.12
52 Week High
$27.98
$90.00

Technical Indicators

Market Signals
Indicator
PLSE
WD
Relative Strength Index (RSI) 60.27 47.31
Support Level $17.58 $48.44
Resistance Level $27.14 $52.44
Average True Range (ATR) 1.86 2.05
MACD 0.45 -0.52
Stochastic Oscillator 76.82 29.02

Price Performance

Historical Comparison
PLSE
WD

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: